Hepatoprotective Evaluation of Ganoderma lucidum Pharmacopuncture: In vivo Studies of Ethanol-induced Acute Liver Injury
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Objectives: Alcohol abuse is a public issue and one of the major causes of liver disease worldwide. This study was aimed at investigating the protective effect of Ganoderma lucidum pharmacopuncture (GLP) against hepatotoxicity induced by acute ethanol (EtOH) intoxication in rats. Methods: Sprague-Dawley (SD) rats were divided into 4 groups of 8 animals each: normal, control, normal saline pharmacopuncture (NP) and GLP groups. The control, NP and GLP groups received ethanol orally. The NP and the GLP groups were treated daily with injections of normal saline and Ganoderma lucidum extract, respectively. The control group received no treatment. The rats in all groups, except the normal group, were intoxicated for 6 hours by oral administration of EtOH (6 g/kg BW). The same volume of distilled water was administered to the rats in the normal group. Two local acupoints were used: Qimen (LR14) and Taechung (LR3). A histopathological analysis was performed, and the liver function and the activities of antioxidant enzymes were assessed. Results: GLP treatment reduced the histological changes due to acute liver injury induced by EtOH and significantly reduced the increase in the alanine aminotransferase (ALT) enzyme; however, it had an insignificant effect in reducing the increase in aspartate aminotransferase (AST) enzyme. It also significantly ameliorated the superoxide dismutase (SOD) and the catalase (CAT) activities. Conclusion: The present study suggests that GLP treatment is effective in protecting against ethanol-induced acute hepatic injury in SD rats by modulating the activities of ethanol-metabolizing enzymes and by attenuating oxidative stress.
Abstract
Objectives: Alcohol abuse is a public issue and one of the major causes of liver disease worldwide. This study was aimed at investigating the protective effect of Ganoderma lucidum pharmacopuncture (GLP) against hepatotoxicity induced by acute ethanol (EtOH) intoxication in rats. Methods: Sprague-Dawley (SD) rats were divided into 4 groups of 8 animals each: normal, control, normal saline pharmacopuncture (NP) and GLP groups. The control, NP and GLP groups received ethanol orally. The NP and the GLP groups were treated daily with injections of normal saline and Ganoderma lucidum extract, respectively. The control group received no treatment. The rats in all groups, except the normal group, were intoxicated for 6 hours by oral administration of EtOH (6 g/kg BW). The same volume of distilled water was administered to the rats in the normal group. Two local acupoints were used: Qimen (LR14) and Taechung (LR3). A histopathological analysis was performed, and the liver function and the activities of antioxidant enzymes were assessed. Results: GLP treatment reduced the histological changes due to acute liver injury induced by EtOH and significantly reduced the increase in the alanine aminotransferase (ALT) enzyme; however, it had an insignificant effect in reducing the increase in aspartate aminotransferase (AST) enzyme. It also significantly ameliorated the superoxide dismutase (SOD) and the catalase (CAT) activities. Conclusion: The present study suggests that GLP treatment is effective in protecting against ethanol-induced acute hepatic injury in SD rats by modulating the activities of ethanol-metabolizing enzymes and by attenuating oxidative stress.
참고문헌 (48)
- Singal AK., "Liver transplantation in alcoholic liver disease current status and controversies", World J Gastroenterol, 19(36), pp.5953~5963 (2013)
- Gao B., "Alcoholic liver disease : pathogenesis and new therapeutic targets", Gastroenterology, 141(5), pp.1572~1585 (2011)
- Osterreicher CH., "Evaluation of the transforming growth factor beta1 codon 25(Arg → Pro)polymorphism in alcoholic liver disease", Cytokine, 42(1), pp.18~23 (2008)
- Meier P., "Age, alcohol metabolism and liver disease", Curr Opin Clin Nutr Metab Care, 11(1), pp.21~26 (2008)
- Tuma DJ., "Dangerous byproducts of alcohol breakdown-focus on adducts", Alcohol Res Health, 27(4), pp.285~290 (2003)
- Albano E., "Hydroxyethyl radicals in ethanol hepatotoxicity", Front Biosci, 4, pp.533~540 (1999)
- Wu D., "Alcohol, oxidative stress, and free radical damage", Alcohol Res Health, 27(4), pp.277~284 (2003)
- Leung TM., "CYP2E1 and oxidant stress in alcoholic and non-alcoholic fatty liver disease", J Hepatol, 58(2), pp.395~398 (2013)
- Cederbaum AI., "Role of oxidative stress in alcohol-induced liver injury", Arch Toxicol, 83(6), pp.519~548 (2009)
- Wu D., "Oxidative stress and alcoholic liver disease", Semin Liver Dis, 29(2), pp.141~154 (2009)
- Koch OR., "Oxidative stress and antioxidant defenses in ethanol-induced cell injury", Mol Aspects Med, 25(1-2), pp.191~198 (2004)
- Singh M., "Evaluation of the oxidative stress in chronic alcoholics", J Clin Diagn Res, 7(8), pp.1568~1571 (2013)
- Zeng T., "The activation of HO-1", Nrf-2 contributes to the protective effects of diallyl disulfide(DADS)against ethanol-induced oxidative stress, 2013, pp.1830(10), 4848~4859
- Bianchi GP., "Reduced ubiquinone plasma levels in patients with liver cirrhosis and in chronic alcoholics", Liver, 14(3), pp.138~140 (1994)
- Jungdae Kim, "A Descriptive Statistical Approach to the Korean Pharmacopuncture Therapy", Journal of Acupuncture & Meridian Studies, 3(3), pp.141~149 (2010), 사단법인약침학회
- Yin CS., "Korean acupuncture: the individualized and practical acupuncture", NEUROLOGICAL RESEARCH, 29(Suppl 1), pp.10~15 (2007), MANEY PUBLISHING
- Xu Z., "Ganoderma lucidum polysaccharides : immunomodulation and potential anti-tumor activities", Am J Chin Med, 39(1), pp.15~27 (2011)
- Weng CJ., "The in vitro and in vivo experimental evidences disclose the chemopreventive effects of ganoderma lucidum on cancer invasion and metastasis", Clin Exp Metastasis, 27(5), pp.361~369 (2010)
- Sanodiya BS., "Ganoderma lucidum : a potent pharmacological macrofungus", Curr Pharm Biotechnol, 10(8), pp.717~742 (2009)
- Boh B., "Ganoderma lucidum and its pharmaceutically active compounds", Biotechnol Annu Rev, 13, pp.26~ (2007)
- Chen P., "A novel soluble beta-glucan salecan protects against acute alcoholinduced hepatotoxicity in mice. Bioscience", Biotechnology and Biochemistry, 75, pp.1990~1993 (2011)
- Misra HP., "The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase", J Biol Chem, 247(10), pp.3170~3175 (1972)
- Reuben A., "Alcohol and the liver", Curr Opin Gastroenterol, 22(3), pp.263~271 (2006)
- Bergheim I., "Treatment of alcoholic liver disease", Dig Dis, 23(3-4), pp.275~284 (2005)
- Maddrey WC., "Alcohol-induced liver disease", Clin Liver Dis, 4(1), pp.115~131 (2000)
- Nordmann R., "Alcohol and antioxidant systems", Alcohol and Alcoholism, 29(5), pp.513~522 (1994)
- Kurose I., "Oxidative stress on mitochondria and cell membrane of cultured rat hepatocytes and perfused liver exposed to ethanol", Gastroenterology, 112(4), pp.1331~1343 (1997)
- Rouach H., "Effect of chronic ethanol feeding on lipid peroxidation and protein oxidation in relation to liver pathology", Hepatology, 25(2), pp.351~355 (1997)
- Wieland P., "Oxidation of mitochondrial proteins and DNA following administration of ethanol", Biochem Biophys Res Commun, 213(3), pp.815~819 (1995)
- Masini A., "Lipid hydroperoxide induced mitochondrial dysfunction following acute ethanol intoxication in rats. the critical role for mitochondrial reduced glutathione", Biochem Pharmacol, 47(2), pp.217~224 (1994)
- Bury RW., "The effect of ethanol administration on the disposition and elimination of chlormethiazole", Eur J Clin Pharmacol, 24(3), pp.383~385 (1983)
- Nagy LE., "Molecular aspects of alcohol metabolism : transcription factors involved in early ethanol-induced liver injury", Annu Rev Nutr, 24, pp.55~78 (2004)
- Zeng T., "Ethanol and liver : recent advances in the mechanisms of ethanol-induced hepatosteatosis", Arch Toxicol, 83(12), pp.1075~1081 (2009)
- 김영주, "The Effect of Needle-embedding Therapy and Pharmacopuncture Therapy on Patients with Urinary Incontinence", Journal of Acupuncture & Meridian Studies, 4(4), pp.220~224 (2011), 사단법인약침학회
- Boh B., "Ganoderma lucidum : a potential for biotechnological production of anti-cancer and immunomodulatory drugs", Recent Pat Anticancer Drug Discov, 8(3), pp.255~287 (2013)
- Wu GS., "Anti-cancer properties of triterpenoids isolated from Ganoderma lucidum-a review", Expert Opin Investig Drugs, 22(8), pp.981~992 (2013)
- Wu X., "Hepatoprotective effects of aqueous extract from lingzhi or reishi medicinal mushroom Ganoderma lucidum(higher basidiomycetes)on α-amanitin-induced liver injury in mice", Int J Med Mushrooms, 15(4), pp.383~391 (2013)
- Orman ES., "Alcoholic liver disease: pathogenesis, management, and novel targets for therapy", J Gastroenterol Hepatol, 28(Suppl 1), pp.77~84 (2013)
- Crawford JM., "Histologic findings in alcoholic liver disease", Clin Liver Dis, 16(4), pp.699~716 (2012)
- Helander A., "Biological markers in alcoholism", J Neural Transm Suppl, (66), pp.15~32 (2003)
- Sharpe PC., "Biochemical detection and monitoring of alcohol abuse and abstinence", Ann Clin Biochem, 38(6), pp.652~664 (2001)
- Panda V., "Antioxidant and hepatoprotective effect of garcinia indica fruit rind in ethanol-induced hepatic damage in rodents", Interdiscip Toxicol, 5(4), pp.207~213 (2012)
- Conigrave KM., "Traditional markers of excessive alcohol use", Addiction, 98(Suppl 2), pp.31~43 (2003)
- Amacher DE., "Serum transaminase elevations as indicators of hepatic injury following the administration of drugs", Regul Toxicol Pharmacol, 27(2), pp.119~130 (1998)
- Dey A., "Alcohol and oxidative liver injury", Hepatology, 43(Suppl 1), pp.S63~S74 (2006)
- Singal AK., "Antioxidants as therapeutic agents for liver disease", Liver Int, 31(10), pp.1432~1448 (2011)
- Dinda PK., "Role of xanthine oxidase-derived oxidants and leukocytes in ethanol-induced jejunal mucosal injury", Dig Dis Sci, 41(12), pp.2461~2470 (1996)
- Thuluvath PJ., "Selenium in chronic liver disease", J Hepatol, 14(2-3), pp.176~182 (1992)